SEP 4, 2026 · JOURNAL ARTICLE
Experimental evolution of phage K enhances antibacterial activity against USA300 MRSA in lung infection models.
Emerging Microbes & Infections
Experimental evolution study using in vitro and ex vivo models to characterize an adapted phage variant; no animal infection efficacy data, clinical outcomes, or in vivo proof of concept reported.
Study details
DesignExperimental evolution study with in vitro…
InterventionEvolved phage KJ25 (derivative of phage K w…
ComparatorWild-type phage K